Who founded PreDxion Bio?

PreDxion Bio was founded by Walker McHugh, Timothy Cornell in 2017.

Who are PreDxion Bio's investors?

PreDxion Bio's investors include Y Combinator, Agrolimen Ventures, Hillsven, Invest Detroit, SignalFire.

Where is PreDxion Bio headquartered?

PreDxion Bio is headquartered in San Francisco, US.

PreDxion Bio

DefunctYC S17

San Francisco, US · Founded 2017 · 6 employees · 5 known investors

Find your way into PreDxion Bio

Paths you didn't know you had: your email and LinkedIn already hold routes to the PreDxion Bio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.

Healthtech Medical Devices Microfluidics Nanosensors COVID-19United States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S17)

PreDxion Bio was founded in 2017 by Walker McHugh and Timothy Cornell.

Walker McHugh FounderHe holds an undergraduate degree in immunology and a graduate degree from the Medical Product Development Program at the University of Michigan College of Engineering.

Timothy CornellFounder

Caroline LandauCOO

Steven KayeVice President, Engineering

Investors · 5

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Agrolimen Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

HillsvenreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Invest DetroitreportedDetroit

How we know: Y Combinator's founder network · Not right? Tell us

SignalFirereportedSan Francisco · $250K – $15M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Indee LabsIndee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.

Correlia BiosystemsCorrelia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL. Aimed at pharmaceutical and proteomics researchers, it offers a faster alternative to traditional ELISA for protein measurement in laboratory workflows.

Astek DiagnosticsAstek Diagnostics develops a diagnostic platform for rapid and accurate detection of urinary tract infections and related conditions in clinical specimens. The company serves physicians and patients needing point-of-care diagnostic solutions for infectious diseases.

Persist AIPersist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.

GTRACK TechnologiesGTRACK Technologies develops fluorescent nanoparticle tracers used to map subsurface fluid flow in geothermal and oil and gas reservoirs.

Companies working in the same space as PreDxion Bio.

Legal entities · 1

corporate structure

PreDxion Bio, Inc.

Frequently asked questions

What does PreDxion Bio do?: PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.
Who founded PreDxion Bio?: PreDxion Bio was founded by Walker McHugh, Timothy Cornell in 2017.
Who are PreDxion Bio's investors?: PreDxion Bio's investors include Y Combinator, Agrolimen Ventures, Hillsven, Invest Detroit, SignalFire.
Where is PreDxion Bio headquartered?: PreDxion Bio is headquartered in San Francisco, US.